Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment

被引：0
|
作者：
Mehmet Akce
Anthony El-Khoueiry
Sarina A. Piha-Paul
Emeline Bacque
Peng Pan
Zhi-Yi Zhang
Reginald Ewesuedo
Divya Gupta
Yongqiang Tang
Ashley Milton
Stefan Zajic
Patricia L. Judson
Cindy L. O’Bryant
机构：
[1] Winship Cancer Institute of Emory University,
[2] University of Southern California Norris Comprehensive Cancer Center,undefined
[3] University of Texas MD Anderson Cancer Center,undefined
[4] GlaxoSmithKline,undefined
[5] EQRx,undefined
[6] Dyne Therapeutics,undefined
[7] Mersana Therapeutics,undefined
[8] GlaxoSmithKline,undefined
[9] University of Colorado Cancer Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2021年 / 88卷
关键词：
Niraparib; Pharmacokinetics; Safety; Dosing; Hepatic impairment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：825 / 836
页数：11
相关论文
共 50 条
  • [1] Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment
    Akce, Mehmet
    El-Khoueiry, Anthony
    Piha-Paul, Sarina A.
    Bacque, Emeline
    Pan, Peng
    Zhang, Zhi-Yi
    Ewesuedo, Reginald
    Gupta, Divya
    Tang, Yongqiang
    Milton, Ashley
    Zajic, Stefan
    Judson, Patricia L.
    O'Bryant, Cindy L.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (05) : 825 - 836
  • [2] Pharmacokinetics and safety following a single oral dose of niraparib in patients with moderate hepatic impairment.
    Akce, Mehmet
    El-Khoueiry, Anthony B.
    Piha-Paul, Sarina Anne
    Bacque, Emeline
    Pan, Peng
    Zhang, Zhi-Yi
    Ewesuedo, Reginald
    Gupta, Divya
    Milton, Ashley
    Judson, Patricia
    O'Bryant, Cindy L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] An effect of moderate hepatic impairment on the pharmacokinetics and safety of darapladib
    Magee, Mindy He
    Shearn, Shawn
    Shaddinger, Bonnie
    Fang, Zixing
    Glaser, Ruchira
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (05) : 1014 - 1021
  • [4] EFFECT OF MODERATE HEPATIC IMPAIRMENT ON THE SAFETY AND PHARMACOKINETICS OF REZAFUNGIN
    Ong, Voon
    Sandison, Taylor
    Melara, Rebeca
    Marbury, Thomas
    Huguet, Jade
    Jandourek, Alena
    Flanagan, Shawn
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 334 - 334
  • [5] The pharmacokinetics and safety of idelalisib in subjects with moderate or severe hepatic impairment
    Jin, Feng
    Robeson, Michelle
    Zhou, Huafeng
    Hisoire, Grace
    Ramanathan, Srini
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (08): : 944 - 952
  • [6] Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics and Safety of Carisbamate
    Moore, Kenneth
    Zannikos, Peter
    Solanki, Bhavna
    Greenspan, Andrew
    Verhaeghe, Tom
    Brashear, H. Robert
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (05): : 738 - 746
  • [7] Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment
    Grasela, DM
    Christofalo, B
    Kollia, GD
    Duncan, G
    Noveck, R
    Manning, JA
    LaCreta, FP
    [J]. PHARMACOTHERAPY, 2000, 20 (06): : 87S - 94S
  • [8] Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment
    Rolfo, Christian
    Isambert, Nicolas
    Italiano, Antoine
    Molife, L. Rhoda
    Schellens, Jan Hm
    Blay, Jean-Yves
    Decaens, Thomas
    Kristeleit, Rebecca
    Rosmorduc, Olivier
    Demlova, Regina
    Lee, Myung-Ah
    Ravaud, Alain
    Kopeckova, Katerina
    Learoyd, Maria
    Bannister, Wendy
    Locker, Gershon
    de Vos-Geelen, Judith
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (09) : 1807 - 1818
  • [9] Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment
    Almeida, Luis
    Potgieter, J. Hendrick
    Maia, Joana
    Potgieter, M. Alida
    Mota, Fernando
    Soares-da-Silva, P.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (03) : 267 - 273
  • [10] Pharmacokinetics of Rolapitant in Patients With Mild to Moderate Hepatic Impairment
    Wang, Jing
    Wang, Xiaodong
    Zhang, Zhi-Yi
    Arora, Sujata
    Lu, Sharon
    Kansra, Vikram
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (05): : 686 - 693
12345